Parabon NanoLabs wins NSF grant to develop cancer drugs

07/21/2009 | American City Business Journals

The National Science Foundation awarded a $100,000 grant to Parabon NanoLabs, a subsidiary of Parabon Computation, to develop cancer treatments using its DNA nanotechnology fabrication and grid computing sequence optimization. Parabon's research will focus on novel anti-cancer molecules that have the ability to self-assemble from interlocking strands of synthetic DNA.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL